Streetbeat News

Products Services

SGAMY

SEGA executive Osamu Ohasi has expressed his ambition for Sonic the Hedgehog to surpass Mario in terms of popularity. Ohasi, who manages SEGA's 2nd Business Department responsible for the Sonic franchise, wants Sonic to be played globally and the Sonic movie to be a bigger hit than Mario. However, achieving these objectives will be challenging as the recent Super Mario Bros. movie grossed $1.36 billion at the box office, while the two Sonic movies combined generated a total of $725 million. In terms of video game sales, Mario is the best-selling video game franchise of all time, with over 830 million copies sold globally.

Portfolio Pulse from Franca Quarneti

November 03, 2023 | 8:53 pm

ALGS

Aligos Therapeutics, Inc. (NASDAQ:ALGS) will host a virtual KOL event to review the Late Breaking results and next steps for ALG-000184, its Phase 1 CAM-E drug candidate for chronic Hepatitis B (CHB). The event will feature Mark Sulkowski, MD, Professor of Medicine at the Johns Hopkins University School of Medicine, and will take place on November 16, 2023. The Phase 1 data are being featured in a late breaking poster session at the Liver Meeting® of the American Association of Liver Disease on November 13, 2023.

Portfolio Pulse from Benzinga Newsdesk

November 03, 2023 | 8:32 pm

ELTX

Elicio Therapeutics (NASDAQ:ELTX) has presented updated preliminary data from its ongoing Phase 1 study of ELI-002, a therapeutic cancer vaccine, and new preclinical data on ELI-007 and ELI-008 at the Society for Immunotherapy of Cancer Annual Meeting. The data shows promising results in patients with high relapse risk mKRAS-driven pancreatic and colorectal cancers. The strength of the induced T cell response correlated with a significantly reduced risk of relapse and death. ELI-007 and ELI-008 also demonstrated strong induction of tumor-antigen-specific T cell responses in mice.

Portfolio Pulse from Benzinga Newsdesk

November 03, 2023 | 8:31 pm

PFE

SGMO

Sangamo Therapeutics Inc has announced that Pfizer expects a pivotal readout in the Phase 3 Affine trial evaluating Giroctocogene Fitelparvovec in the middle of 2024, according to an SEC filing.

Portfolio Pulse from Benzinga Newsdesk

November 03, 2023 | 8:10 pm

SRRK

Scholar Rock has presented new data from its Phase 1 DRAGON trial, showing anti-tumor activity in anti-PD-1 resistant metastatic ccRCC patients. The data supports the continued tolerability of SRK-181 and shows a disease control rate of 57% and an objective response rate of 21.4%. The company will discuss the SRK-181 program during a conference call on its Q3 2023 financial results and business updates.

Portfolio Pulse from Benzinga Newsdesk

November 03, 2023 | 8:01 pm

KA

Kineta, Inc. (NASDAQ:KA) presented new preclinical data on its lead anti-CD27 monoclonal antibody at the Society for Immunotherapy of Cancer's 38th Annual Meeting. The data showed high binding affinity and specificity, strong T cell activation and proliferation, and NK cell activation. The antibody demonstrated in vivo antitumor efficacy as a single agent and in combination with other immunotherapies in multiple solid and hematological mouse tumor models.

Portfolio Pulse from Benzinga Newsdesk

November 03, 2023 | 8:01 pm

AAPL

DIS

The 2023 Rock & Roll Hall of Fame Induction Ceremony will be streamed live on Walt Disney Company's Disney+ and Apple Inc's Apple Music. The event will remain available to stream following the ceremony. The inductees include Kate Bush, Missy Elliott, George Michael, Sheryl Crow, Rage Against the Machine, The Spinners and Willie Nelson.

Portfolio Pulse from Maureen Meehan

November 03, 2023 | 7:49 pm

ARMK

ETN

HCA

PLTR

Palantir Technologies Inc. (NYSE:PLTR) CEO Alex Karp expressed confidence in the company's Artificial Intelligence Platform (AIP) and U.S. commercial during the recent earnings call. The company's AIP has tripled its user base in five months and has 300 distinct organizations signed up, including Tampa General, HCA Healthcare Inc (NYSE:HCA), Cleveland Clinic, Aramark (NYSE:ARMK), Panasonic North America, Eaton Corp PLC (NYSE:ETN), and Carrefour Brazil. Palantir also expects its U.S. commercial segment to grow over 10% YoY.

Portfolio Pulse from Surbhi Jain

November 03, 2023 | 7:25 pm

VUZI

Vuzix has completed the delivery of a customized waveguide-based optics engine to a Tier-1 Aerospace and Defense firm. The engine is designed for use in head worn systems for aerospace applications, offering high brightness, high index waveguide design with a wide field-of-view.

Portfolio Pulse from Benzinga Newsdesk

November 03, 2023 | 6:42 pm

NTDOY

Nintendo ADR (OTC:NTDOY) has launched an initiative to place its Switch consoles in senior centers in Japan, offering a selection of games tailored to the preferences of the elderly. The company plans to expand this initiative to 200 senior centers, following positive feedback from initial smaller-scale events. Nintendo also confirmed plans to support the Switch with new games until at least March 2025 and is preparing to release a next-generation console in late 2024.

Portfolio Pulse from Franca Quarneti

November 03, 2023 | 6:34 pm